LogicMark (LGMK) Competitors $0.02 0.00 (-3.54%) As of 03:35 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LGMK vs. BJDX, TIVC, VERO, NAYA, AVGR, QNRX, HSDT, AFIB, NVIVQ, and STSSShould you be buying LogicMark stock or one of its competitors? The main competitors of LogicMark include Bluejay Diagnostics (BJDX), Tivic Health Systems (TIVC), Venus Concept (VERO), NAYA Biosciences (NAYA), Avinger (AVGR), Quoin Pharmaceuticals (QNRX), Helius Medical Technologies (HSDT), Acutus Medical (AFIB), Invivo Therapeutics (NVIVQ), and Sharps Technology (STSS). These companies are all part of the "medical equipment" industry. LogicMark vs. Bluejay Diagnostics Tivic Health Systems Venus Concept NAYA Biosciences Avinger Quoin Pharmaceuticals Helius Medical Technologies Acutus Medical Invivo Therapeutics Sharps Technology Bluejay Diagnostics (NASDAQ:BJDX) and LogicMark (NASDAQ:LGMK) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, dividends, media sentiment, institutional ownership, community ranking and risk. Which has more risk & volatility, BJDX or LGMK? Bluejay Diagnostics has a beta of 0.38, suggesting that its share price is 62% less volatile than the S&P 500. Comparatively, LogicMark has a beta of 1.36, suggesting that its share price is 36% more volatile than the S&P 500. Which has stronger valuation & earnings, BJDX or LGMK? Bluejay Diagnostics has higher earnings, but lower revenue than LogicMark. Bluejay Diagnostics is trading at a lower price-to-earnings ratio than LogicMark, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBluejay Diagnostics$250K8.21-$9.95M-$1.37 thousand0.00LogicMark$10.08M0.01-$14.55M-$223.500.00 Is BJDX or LGMK more profitable? Bluejay Diagnostics has a net margin of 0.00% compared to LogicMark's net margin of -141.96%. LogicMark's return on equity of -124.91% beat Bluejay Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets Bluejay DiagnosticsN/A -155.67% -117.82% LogicMark -141.96%-124.91%-92.05% Does the MarketBeat Community believe in BJDX or LGMK? Bluejay Diagnostics received 2 more outperform votes than LogicMark when rated by MarketBeat users. CompanyUnderperformOutperformBluejay DiagnosticsOutperform Votes266.67% Underperform Votes133.33% LogicMarkN/AN/A Does the media refer more to BJDX or LGMK? In the previous week, LogicMark had 1 more articles in the media than Bluejay Diagnostics. MarketBeat recorded 4 mentions for LogicMark and 3 mentions for Bluejay Diagnostics. Bluejay Diagnostics' average media sentiment score of 1.43 beat LogicMark's score of 0.36 indicating that Bluejay Diagnostics is being referred to more favorably in the media. Company Overall Sentiment Bluejay Diagnostics Positive LogicMark Neutral Do institutionals and insiders believe in BJDX or LGMK? 18.5% of Bluejay Diagnostics shares are owned by institutional investors. Comparatively, 7.9% of LogicMark shares are owned by institutional investors. 0.4% of Bluejay Diagnostics shares are owned by insiders. Comparatively, 1.3% of LogicMark shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. SummaryLogicMark beats Bluejay Diagnostics on 8 of the 14 factors compared between the two stocks. Remove Ads Get LogicMark News Delivered to You Automatically Sign up to receive the latest news and ratings for LGMK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LGMK vs. The Competition Export to ExcelMetricLogicMarkSurgical appliances & supplies IndustryIndustrials SectorNASDAQ ExchangeMarket Cap$96,000.00$8.90B$6.83B$7.87BDividend YieldN/A1.42%3.55%4.05%P/E Ratio0.0018.2821.6918.73Price / Sales0.0169.2975.1189.10Price / CashN/A19.6726.7834.64Price / Book0.005.413.664.14Net Income-$14.55M$284.66M$793.46M$246.93M7 Day PerformanceN/A-5.03%-0.79%-3.25%1 Month PerformanceN/A-5.75%-1.64%-6.24%1 Year PerformanceN/A-22.45%17.01%-1.44% LogicMark Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LGMKLogicMark0.4246 of 5 stars$0.02-3.5%N/A-99.9%$96,000.00$10.08M0.0020News CoverageHigh Trading VolumeBJDXBluejay Diagnostics1.117 of 5 stars$3.93-6.2%N/A-98.8%$2.17M$250,000.000.009Earnings ReportGap DownTIVCTivic Health Systems0.5864 of 5 stars$3.41-3.9%N/A-88.0%$2.09M$957,000.000.0010Short Interest ↓Positive NewsGap DownVEROVenus Concept0.4575 of 5 stars$3.11+0.3%N/A-63.3%$2.05M$67.20M-0.39410Earnings ReportUpcoming EarningsShort Interest ↑News CoverageNAYANAYA BiosciencesN/A$2.41-12.0%$24.00+895.9%N/A$1.61M$6.23M0.0010High Trading VolumeAVGRAvingerN/A$0.47flatN/AN/A$1.57M$7.26M-0.0470QNRXQuoin Pharmaceuticals1.1091 of 5 stars$0.30-1.3%N/A-76.4%$1.50MN/A-0.074HSDTHelius Medical Technologies0.2464 of 5 stars$0.40-8.1%N/A-93.1%$1.47M$502,000.00-0.0630Earnings ReportGap UpAFIBAcutus MedicalN/A$0.05+3.9%N/A-77.3%$1.42M$7.16M0.00340NVIVQInvivo TherapeuticsN/A$0.37flatN/AN/A$1.15MN/A0.006High Trading VolumeSTSSSharps Technology0.1715 of 5 stars$0.17-21.6%N/AN/A$938,000.00N/A-0.023Earnings ReportUpcoming EarningsGap Down Remove Ads Related Companies and Tools Related Companies BJDX Competitors TIVC Competitors VERO Competitors NAYA Competitors AVGR Competitors QNRX Competitors HSDT Competitors AFIB Competitors NVIVQ Competitors STSS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LGMK) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LogicMark, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LogicMark With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.